What is the recommended evaluation and treatment for a 20‑year‑old female presenting with hair loss and normal laboratory studies, including thyroid‑stimulating hormone (TSH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Treatment for a 20-Year-Old Female with Hair Loss and Normal TSH

Start topical minoxidil 5% (foam or solution) as first-line treatment, and complete additional laboratory workup to identify treatable contributing factors and rule out androgen excess. 1

Immediate Next Steps in Evaluation

Since TSH is normal, proceed with the following mandatory and recommended laboratory tests:

Mandatory Testing

  • Androgen assessment 1:
    • Total testosterone using high-quality assay (preferably LC/MS or immunoassay with extraction/purification)
    • Free testosterone (via equilibrium dialysis, ultracentrifugation, or calculated using SHBG)
    • SHBG (sex hormone-binding globulin)

Recommended Additional Testing

The following labs help identify treatable conditions that may impair hair regrowth 1:

  • Ferritin (though evidence for treatment benefit is uncertain, many patients with female pattern hair loss [FPHL] have levels <70 ng/mL)
  • Vitamin D (25-hydroxyvitamin D) (62% of FPHL patients have low levels)
  • Zinc (15% of FPHL patients have deficiency)
  • Prolactin
  • Complete blood count (to assess for anemia)

Clinical Examination Requirements

Perform a thorough scalp examination looking for 1:

  • Pattern of hair loss: Centrifugal expansion in mid-scalp OR frontal accentuation ("Christmas tree" pattern) suggests FPHL
  • Scalp inflammation or scarring: Presence suggests alternative diagnoses requiring scalp biopsy
  • Hair pull test: Assess for active shedding
  • Signs of hyperandrogenism: Hirsutism, acne, or other virilization signs

Consider dermatoscopic examination or scalp biopsy if the diagnosis is unclear or if scarring/inflammatory changes are present 1.

First-Line Treatment

Topical minoxidil 5% is the only treatment with sufficient evidence and should be started immediately 1:

  • Formulation options:

    • 5% foam once daily, OR
    • 5% solution twice daily
    • (5% foam once daily is equivalent to 2% solution twice daily and has fewer side effects)
  • Important counseling points:

    • Expect transient increased shedding in first 2-8 weeks (telogen hairs shedding to make room for new anagen growth)
    • Must use for at least 12 months for optimal results
    • Side effects: scalp pruritus/flaking (more common with solution due to propylene glycol), facial hypertrichosis (more common with 5% formulations)

When to Add Systemic Therapy

Add antiandrogen or 5α-reductase inhibitor if 1:

  • Severe hair loss, OR
  • Evidence of hyperandrogenism (elevated androgens or clinical signs)

Systemic Treatment Options for Reproductive-Age Women

Critical warning: All systemic options are teratogenic and require strict contraception during treatment and for at least 30 days after discontinuation 1.

Preferred options (lowest risk profile):

  1. Spironolactone 100-200 mg/day 1

    • Better response in patients with hirsutism or acne
    • Requires at least 12 months of treatment
  2. Finasteride 2.5-5 mg/day 1

    • Note: 1 mg daily is ineffective in premenopausal women
    • Higher doses (2.5-5 mg) show benefit, particularly in hyperandrogenic patients

Not recommended:

  • Flutamide: Risk of hepatotoxicity outweighs benefits 1
  • Cyproterone acetate: Unclear effectiveness 1

Common Pitfalls to Avoid

  1. Don't assume normal TSH rules out all endocrine causes: Androgen excess is common in FPHL and must be evaluated 1

  2. Don't supplement iron/vitamin D/zinc without documented deficiency: Evidence that correction improves hair growth is lacking, even when deficiencies are present 1

  3. Don't use finasteride 1 mg daily in premenopausal women: This dose is ineffective; requires 2.5-5 mg daily 1

  4. Don't delay minoxidil while waiting for lab results: Start treatment immediately as it requires 12+ months to see benefit 1

  5. Don't forget contraception counseling: If systemic antiandrogens or 5α-reductase inhibitors are considered, ensure reliable contraception is in place first 1

Interpretation of Androgen Results

  • If testosterone is >2× upper limit of normal: Check DHEAS to rule out adrenal tumor (DHEAS >600 µg/dL suggests adrenal source requiring imaging) 2
  • If androgens are normal: Isolated FPHL with normal androgen levels should NOT be considered a sign of hyperandrogenism 1
  • If androgens are elevated: Consider PCOS, ovarian hyperthecosis, or androgen-secreting tumor depending on degree of elevation

Expected Timeline

  • Minoxidil: Minimum 12 months for optimal results 1
  • Systemic antiandrogens: At least 12 months required 1
  • Follow-up: Schedule reassessment at 6 and 12 months to evaluate response and reinforce adherence

References

Related Questions

What is the appropriate next step in evaluating and managing a patient who reports increased hair loss, denies weight loss, has normal laboratory studies, and no evidence of thyroid disease?
What evaluation and management are indicated for a 33-year-old woman with significant hair loss, severe abdominal cramping, low folate, low iron, and low estradiol levels?
Given my recent dry, flaky facial skin and a normal thyroid panel two months ago, why am I now experiencing hair loss and what evaluation and treatment steps should I take?
After stopping levothyroxine for a thyroid disorder, is occasional loss of 15–20 hairs in a single pull normal, and what evaluation or treatment is recommended?
What is the appropriate workup for hair loss in a 62-year-old female?
What are the discharge criteria and how can a rapid decline in platelet count be prevented?
What is your assessment and recommended work‑up for an 80‑year‑old man with a history of coronary artery bypass graft (CABG) performed 10 years ago, recent bereavement, two weeks of persistent dizziness, episodic severe hypertension, frequent vomiting, and a normal electrocardiogram (ECG), when his provider attributes the symptoms to a psychological cause?
What role does dermatology play in the management of systemic lupus erythematosus (SLE)?
Should I coordinate care with psychiatry for a patient with dementia?
Should a patient with varicose veins and heterozygous Factor V Leiden mutation, who experienced an unprovoked deep vein thrombosis (DVT) on [date] and a provoked deep vein thrombosis in the same leg on [date], be placed on lifelong anticoagulation?
What is the appropriate treatment plan for a patient with severe cellulitis of the left thigh who also has Addison's disease, malabsorption, and gastroparesis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.